Silencing MEG3 protects PC12 cells from hypoxic injury by targeting miR-21
Source abstract
Abstract
Increasing number of literatures highlighted lncRNA maternally expressed gene 3 (MEG3) as an emerging target for hypoxic-ischaemic brain damage (HIBD). This study attempted to assess the role of MEG3 in a cell model of HIBD. Expression of MEG3 in PC12 cells was suppressed by siRNA-mediated transfection, after which the cells were subjected to hypoxia. Cell viability, apoptosis, migration and the expression of related proteins were assessed. Furthermore, the downstream gene of MEG3 and its downstream signalling pathways were explored. We found that, down-regulation of MEG3 prevented hypoxic injury in PC12 cells, as hypoxia induced viability loss, apoptosis and migration repression were attenuated by transfection with MEG3 siRNA. Meanwhile, MEG3 acted as a miR-21 sponge. The neuroprotective functions of MEG3 silence were flattened when miR-21 was suppressed. Moreover, the deactivation of PI3K/AKT pathway and the activation of NF-κB pathway induced by hypoxia were attenuated by MEG3 silence. As expected, the effects of MEG3 silence on these two signalling were via miR-21. In conclusion, the neuroprotective effects of MEG3 silence on PC12 cells injured by hypoxia were observed in this study. Mechanistically, the neuroprotective effects of MEG3 silence on PC12 cells were via sponging miR-21 and thus regulating PI3K/AKT and NF-κB pathways.HIGHLIGHTSMEG3 is highly expressed in PC12 cells following hypoxic injury;Silence of MEG3 prevents hypoxia-induced cell damage in PC12 cells;MEG3 acts as a miR-21 sponge;MEG3 sponges miR-21 to regulate PI3K/AKT and NF-κB pathways.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cancer-related molecular mechanisms research · RNA modifications and cancer · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Neurology, Daqing Oilfield General Hospital
Department of Neurology, Hainan General Hospital
References (35)
Show source-provided references
1. 10.1016/j.jped.2015.07.00410.1016/j.jped.2015.07.004 ↗
2. 10.1016/B978-0-444-64074-1.00049-510.1016/B978-0-444-64074-1.00049-5 ↗
3. 10.1007/s11011-017-9965-810.1007/s11011-017-9965-8 ↗
4. 10.1016/j.autrev.2015.05.00410.1016/j.autrev.2015.05.004 ↗
5. 10.1161/CIRCRESAHA.116.30252110.1161/CIRCRESAHA.116.302521 ↗
6. Rafiee A, Riazi-Rad F, Havaskary M, et al. Long noncoding RNAs: regulation, function and cancer. Biotechnol Genet Eng Rev. 2018;3:1–28.
7. 10.18632/oncotarget.1395710.18632/oncotarget.13957 ↗
8. 10.1016/j.biopha.2018.12.06710.1016/j.biopha.2018.12.067 ↗
9. 10.1038/s41419-017-0047-y10.1038/s41419-017-0047-y ↗
10. 10.3389/fncel.2016.0020110.3389/fncel.2016.00201 ↗
11. 10.1080/21691401.2018.147148310.1080/21691401.2018.1471483 ↗
12. Zhou XM, Liu J, Wang Y, et al. Silencing of long noncoding RNA MEG3 enhances cerebral protection of dexmedetomidine against hypoxic-ischemic brain damage in neonatal mice by binding to miR-129-5p. J Cell Biochem. 2018;120(5):7978–7988.
13. 10.1016/j.biopha.2019.10869810.1016/j.biopha.2019.108698 ↗
14. 10.1016/j.neulet.2018.09.06010.1016/j.neulet.2018.09.060 ↗
15. 10.1007/s12192-015-0575-210.1007/s12192-015-0575-2 ↗
16. 10.1002/0471142735.ima03bs11110.1002/0471142735.ima03bs111 ↗
17. Wu Z, He Y, Li D, et al. Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21. Am J Transl Res. 2017;9(7):3326–3335.
18. 10.4062/biomolther.2016.16210.4062/biomolther.2016.162 ↗
19. Zhang LL, Hu D, Zou LH. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21. Eur Rev Med Pharmacol Sci. 2018;22(23):8315–8323.
20. 10.1080/15287394.2018.150256110.1080/15287394.2018.1502561 ↗
21. 10.1016/j.biopha.2018.06.12710.1016/j.biopha.2018.06.127 ↗
22. 10.1007/s12031-018-1093-310.1007/s12031-018-1093-3 ↗
23. 10.1038/s41419-018-0496-y10.1038/s41419-018-0496-y ↗
24. 10.1126/sciadv.aav061810.1126/sciadv.aav0618 ↗
25. 10.1002/jcp.2830210.1002/jcp.28302 ↗
26. 10.1016/j.biopha.2017.05.12210.1016/j.biopha.2017.05.122 ↗
27. 10.1152/physiolgenomics.00158.201010.1152/physiolgenomics.00158.2010 ↗
28. 10.1016/j.celrep.2017.10.02310.1016/j.celrep.2017.10.023 ↗
29. 10.18632/oncotarget.1830810.18632/oncotarget.18308 ↗
30. 10.3389/fnins.2018.0076710.3389/fnins.2018.00767 ↗
31. Li X, Zhang J, Zhu X, et al. Progesterone reduces inflammation and apoptosis in neonatal rats with hypoxic ischemic brain damage through the PI3K/Akt pathway. Int J Clin Exp Med. 2015;8(5):8197–8203.
32. 10.1016/j.neuroscience.2008.07.00710.1016/j.neuroscience.2008.07.007 ↗
33. 10.1016/j.neuint.2013.07.01410.1016/j.neuint.2013.07.014 ↗
34. 10.1161/STROKEAHA.116.01386910.1161/STROKEAHA.116.013869 ↗
35. 10.1186/s12944-018-0941-z10.1186/s12944-018-0941-z ↗